mPharma
PrivateLast Round
Strategic
Nov 3, 2025
Total Funding Raised
$83.63M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
mPharma operates in Healthcare & Life Sciences and is based in Accra. Its latest recorded funding round was a Strategic round in November 2025.
mPharma is a healthcare technology company that manages medicine supply, pricing, and last-mile delivery through a network of partner pharmacies and its Mutti-branded points of care.
Sector
Healthcare & Life Sciences
Verticals
Pharma Supply Chain, Telemedicine, Patient Engagement, E-commerce
Business Model
B2B2C
Customer Profile
Revenue Share, Subscription SaaS, Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
mPharma Comparables
Compare mPharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DrugStoc | 84% | |
| SwipeRx | 83% | |
| Remedial Health | 83% |
For institutional investors. Book with your work email.
mPharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Nov 3, 2025 | ||||
| Grant | Apr 30, 2025 | ||||
| Corporate Funding | Feb 9, 2024 | ||||
| Series D | Jan 5, 2022 | ||||
| Series C | May 26, 2020 | ||||
Grant | Apr 3, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
mPharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Breyer Capital | Series A |
| Golden Palm Investments | Series A, Series B, Seed |
| Novastar Ventures | Series D, Series B, Series C |
| Unbound Ventures | Series B |
| 4DX Ventures | Series A, Series B |
| Oak HC/FT | Series B |
| The Skoll Foundation | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 11, 2026
Job posting indicates team has grown to over 500 members.
- Mar 28, 2026
Added Invimatic, a supply chain technology startup, as a customer.
For institutional investors. Book with your work email.
mPharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about mPharma's valuation, stock price, and market status.
Is mPharma a public or private company?
mPharma is a private company.
What is the current stock price of mPharma?
mPharma is a private company, so its shares have no public market price. Caplight tracks mPharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is mPharma worth (valuation)?
Valuation information for mPharma is not publicly available.
Can I buy mPharma stock?
mPharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was mPharma's last funding round?
mPharma's most recent funding round was Strategic on November 3, 2025.
Who are the main investors in mPharma?
Key investors in mPharma include Novastar Ventures, Lux Capital, NovaStar Ventures, JAM Fund, Social Capital.
Will mPharma IPO soon?
No public IPO plans have been announced for mPharma.
How can I track mPharma secondary market activity?
Caplight tracks bids, offers, and trades in mPharma's shares on secondary markets.